Abstract
Lung cancer is the leading cause of death in many countries. In Japan the mortality of stomach cancer has begun to decrease while that of lung cancer is still increasing (1991: 21% of all cancer deaths in male and 11.5% in female). The reasons for this situation are not only high incidence but also poor prognosis. Significant improvements are expected in all aspects of disease management: detection, diagnosis, staging, treatment, and treatment evaluation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Proto AV, Thomas SR. Pulmonary nodules studied by computed tomography. Radiology 1985; 156: 149–153.
Zerhouni EA, Stitik FP, Siegelman SS, et al. CT of the pulmonarynodule: a cooperative study. Radiology 1986; 160: 319–327.
Siegelman SS, KhouriNF, Leo FP, Fishman EK, Braverman RM, Zerhouni EA. Solitary pulmonary nodules: CT assessment. Radiology 1986; 160: 307–312.
Zwirewick CV, Vedal S, Millar RR, Mueller NL. Solitary pulmonary nodule: high resolution CT and radiologie pathologic correlation. Radiology 1991; 179: 469–476.
Huston J, Muhm JR. Solitary pulmonary nodules: evaluation with a CT reference phantom. Radiology 1989; 170: 653–656.
Staples CA, Mueller NL, Miller RR, Evans KG, Nelems B. Mediastinal nodes in bronchogenic carcinoma: comparison between CT and mediastinoscopy. Radiology 1988; 167: 367–372.
McLoud TC, Bourgouin PM, Greenberg RW et al. Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymphnode mapping and sampling. Radiology 1992; 182: 319–323.
Abdel-Dayem HM, Scott A, Macapinlac H, Larson S. Tracer imaging in lung cancer. Eur J Nuel Med 1994; 21: 57–81.
Tonami N, Shuke N, Yokoyama K,et al. Thallium-201 single photon emission computed tomography in the evaluation of suspected lung cancer. J Nucl Med 1989; 30: 997–1004.
Kubota K, Matsuzawa T, Ito M, et al. Lung tumor imaging by positron emission tomography using C-11-L-methionine. J Nucl Med 1985; 26: 37–42.
Kubota K, Matsuzawa T, Fujiwara T, et al. Differential diagnosis of solitary pulmonary nodules with positron emission tomography. J Comput Assist Tomogr 1988; 12: 794–796.
Kubota K, Matsuzawa T, Fujiwara T, et al. Differential diagnosis of lung tumor with positron emission tomography: a prospective study. J Nucl Med 1990; 31: 1927–1933.
Nolop KB, Rhodes CG, Brudin LH, et al. Glucose utilization in vivo by human pulmonary neoplasms. Cancer 1987; 60: 2682–2689.
Strauss LG, Conti PS. The application of PET in clinical oncology. J Nucl Med 1991; 32: 623–648.
Jacobs MP, Mantil JC, Peterson CD, et al. FDG PET imaging of the chest. J Nucl Med 1992; 33: 975.
Wahl RL, Quint LE, Orringer M, Meyer CH. Staging non-small cell lung cancer in the mediastinum: comparison of FDG-PET, CT and hybrid anatometabolic fusion images with pathology. Radiology 1992; 185 (p): 324.
Slosman DO, Spiliopoulos A, Couson F, et al. Satellite PET and lung cancer: a prospective study in surgical patients. Nucl Med Comm 1993; 14: 955–961.
Patz EF, Lowe VJ, Hoffman JM, et al. Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning. Radiology 1993; 188: 487–490.
Gupta N, Chandramouli B, Reeb S, Dewan N. Diagnostic evaluation of solitary pulmonary nodules. J Nucl Med 1994; 35: 76P, Radiology 1992; 184: 441–444, Chest 1993; 104: 997–1002.
Hubner KF, Smith GT, Raja S, Hunter K, Gould HR, Buonocore E. Positron emission tomography for evaluating chest masses. J Nucl Med 1994; 35: 220 P.
Coleman RE, Cascade E, Gupta NC, Lawson M, Patz E, Rubin RJ. Clinical application and economic implications of PET in assessment of solitary pulmonary nodules: a retrospective study. 1994 Institute for clinical PET, Fairfax VA, USA.
Miyazawa H, Arai T, Iio M, Hara T. PET imaging of non-small-cell lung carcinoma with carbon-11-methionine: relationship between radioactivity uptake and flowcytometric parameters. J Nucl Med 1993; 34: 1886–1891.
Knopp MV, Strauss LG, Bischoff H, et al. Assessment of the potential clinical role of PET in the staging of thoracic adenopathy. Radiology 1991; 181P: 250.
Wahl RL, Quint LE, Greenough RL, Meyer CR, White RI, Orringer MB. Staging of mediastinal non-small cell lung cancer with FDG-PET, CT and fusion images: preliminary prospective evaluation. Radiology 1994; 191: 371–377.
Rege SD, Hoh CK, Glaspy JA, et al. Imaging of pulmonary mass lesions with whole-body positron emission tomography and fluorodeoxyglucose. Cancer 1993; 72: 82–90.
Lewis PJ and Salama A. Uptake of fluorine-l8-fluorodeoxyglucose in sarcoidosis. J Nucl Med 1994; 35: 1647–1649.
Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratumoral distribution of fluorine-l8-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 1992; 33: 1972–1980.
Kim CK, Gupta NC, Chandramouli B, Alavi A. Standardized uptake values of FDG: body surface area correction is preferable to body weight correction. J Nucl Med 1994; 35: 164–167.
Zasadny KR, Wahl RL. Standardized uptake values of normal tissues at PET with (fluorine-18)-fluoro-2-deoxy-D-glucose: variations with body weight and a method for correction. Radiology 1993; 189: 847–850.
Langen KJ, Braun U, Kops R, et al. The influence of plasma glucose levels on fluorine-l8-fluorodeoxyglucose uptake in bronchial carcinomas. J Nucl Med 1993; 34: 355–359.
Hamberg LM, Hunter GJ, Alpert NM, Choi NC, Babich JW, Fischman AJ. The dose uptake ratio as an index of glucose metabolism: useful parameter or oversimplification? J Nucl Med 1994; 35: 1308–1312.
Lindholm P, Leskinen-Kallio S, Kirvela O, et al. Head and neck cancer: effect of food ingestion on uptake of C-11 methionine. Radiology 1994; 190: 863–867.
Kubota K, Matsuzawa T, Takahashi T, et al. Rapid and sensitive response of carbon11-L-methionine tumor uptake to irradiation. J Nucl Med 1989; 30: 2012–2016.
Kubota K, Ishiwata K, Yamada S, et al. Dose-responsive effect of radiotherapy on the tumor uptake of L-methyl-11-C methionine; feasibility for monitoring recurrence of tumor. Nucl Med Biol 1992; 19: 27–32.
Kubota K, Ishiwata K, Kubota R, et al. Tracer feasibility for monitoring tumor radiotherapy: a quadruple tracer study with fluorine-l8-fluorodeoxyglucose or fluorine18-fluorodeoxyuridine, L-methyl-14C methionine,6–3H thymidine, and Gallium-67.J Nucl Med 1991; 32: 2118–2123.
Kubota K, Kubota R, Yamada S. FDG accumulation in tumor tissue (Editorial). J Nucl Med 1993; 34: 419–421.
Kubota K, Yamada S, Ishiwata K, Ito M, Ido T. Positron emission tomography for treatment evaluation and recurrence detection compared with CT in long-term follow-up cases of lung cancer. Clin Nucl Med 1992; 17: 877–881.
Kubota K, Yamada S, Ishiwata K, et al. Evaluation of the treatment response of lung cancer with positron emission tomography and L-methyl-1 1 C methionine:a preliminary study. Eur J Nucl Med 1993; 20: 495–501.
Patz EF, Lowe VJ, Hoffman JM, Paine SS, Harris LK, Goodman PC. Persistent or recurrent bronchogenic carcinoma: detection with PET and 2-(F-18)-2-Deoxy-D glucose. Radiology 1994; 191: 379–382.
Kim EE, Garcia JR, Wong FCL, et al. Differentiation of thoracic tumors from posttreatment changes using PET with F-18 FDG and C-11 Methionine. J Nucl Med 1994; 35: 76 P.
Engenhart R, Kimmig BN, Strauss LG, et al. Therapy monitoring of presacral recurrences after high-dose irradiation: value of PET, CT, CEA and pain score. Strahlen-ther Onkol 1992; 168: 203–212.
Ichiya Y, Kuwabara Y, Otsuka M, et al. Assessment of response to cancer therapy using fluorine-18-fluorodeoxyglucose and positron emission tomography. J Nucl Med 1991; 32: 1655–1660.
Lowe VJ, Hebert ME, Hawk TC, Anscher MS, Coleman RE. Chestwall FDG accumulation in serial FDG-PET images in patients being treated for bronchogenic carcinoma. J Nucl Med 1994; 35: 76 P.
Kubota R, Kubota K, Yamada S, et al. Methionine uptake by tumor tissue: a microautoradiographic comparison with FDG. J Nucl Med 1995.
Kubota K, Kubota R, Yamada S, Tada M. Effects of radiotherapy on the cellular uptake of carbon-14 labeled L-methionine in tumor tissue. Nucl Med Biol 1995.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Kluwer Academic Publishers
About this chapter
Cite this chapter
Kubota, K. et al. (1996). Positron Emission Tomography in Diagnosing Lung Tumors. In: Bares, R.B., Lucignani, G. (eds) Clinical PET. Developments in Nuclear Medicine, vol 28. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-0309-8_6
Download citation
DOI: https://doi.org/10.1007/978-94-009-0309-8_6
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-6624-2
Online ISBN: 978-94-009-0309-8
eBook Packages: Springer Book Archive